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ABSTRACT 
OBJECTIVE: It is unclear whether the association between osteoarthritis (OA) and 
metabolic syndrome (MetS) varies with the site of the affected joint and the presence of pain. 
Our aim was to describe the association between MetS and radiographic OA (ROA) affecting 
the knee or the hand in the presence or absence of concurrent joint pain. 
METHODS: Cross-sectional data of 952 women, aged 45-65 years from from the Chingford 
study, a population-based longitudinal cohort of middle-aged women initiated in 1988-1989 
in London (UK), was analysed. MetS was defined using the National Cholesterol Education 
Program Treatment Panel III criteria. Data was collected on components of MetS: waist 
circumference, triglycerides, high-density lipoprotein (HDL), blood pressure and blood 
glucose. The outcome was four knee and hand OA groups: painful ROA, ROA only, pain 
only and neither ROA nor pain (reference category). Multinomial logistic regression models 
adjusted for age and body mass index (BMI) were used to evaluate the effect of presence of 
MetS and its individual components on OA subgroups for knee and hand separately. 
RESULTS: 952 eligible women, aged 45-65 years was analysed. A significant association 
was observed between the presence and the number of MetS with painful knee ROA when 
adjusted for age; however, this association disappeared when BMI was included in the model. 
In contrast, the presence and the number of MetS were associated with painful 
interphalangeal (IPJ) OA after adjusting for both age and BMI. Four out of the five MetS 
components, including triglycerides, HDL-c, hypertension and glucose, were associated with 
painful IPJ OA.  
CONCLUSIONS: MetS is associated with painful IPJ OA but not with knee OA once BMI 
is taking into consideration.  Further attention to MetS and OA at different sites is needed to 
understand the metabolic phenotype in OA. 
Keywords: Metabolic syndrome, hand, knee, osteoarthritis, pain 
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1. INTRODUCTION 
Osteoarthritis (OA) is the most common form of arthritis and a leading cause of disability in 
the developed world 
1
. The natural history of OA is poorly understood; it is recognised as a 
heterogeneous disease of multifactorial aetiology with shared common radiographic features 
and symptomatology 
2,3
.  
A higher prevalence of metabolic syndrome (MetS), defined as high waist circumference, 
dyslipidaemia (low high-density lipoprotein (HDL) and triglyceridaemia), hypertension and 
insulin resistance, has been reported in patients with OA, even after controlling for identified 
risk factors such as age, sex and body mass index (BMI) or weight 
4-7
. Two previous 
systematic reviews with meta-analyses suggested a strong association between diabetes and 
OA, independent of weight and BMI
8,9
. In contrast, a recent systematic review found little 
evidence to support an association between DM and knee OA and no evidence with hip or 
hand OA was found
10
. A recent meta-analysis demonstrated that hypertension was associated 
with both radiographic and symptomatic knee OA
11
, and another systematic review 
demonstrated an association between dyslipidemia and OA
12
. 
There is evidence for a relationship between visceral fat tissue
13,14
, metabolic syndrome 
(MetS) 
15-17
 and OA and this is expected to translate into higher cardiovascular risk
18
 and 
premature mortality.  
The association between knee and hand OA with systemic metabolic dysregulation is 
controversial. Previous studies of MetS and OA focussed on selected groups of individuals 
with potential confounding by recruitment strategy (often associated with the severity of 
disease).  The Netherlands Epidemiology of Obesity study looked at components of MetS and 
surrogates of mechanical stress in a general population cohort that over-sampled obese and 
overweight individuals 
16
. This cross-sectional study demonstrated that individuals with MetS 
were more likely to have hand and knee OA, even after adjusting for age, sex, smoking, 
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ethnicity and height. In knee OA, this relationship was not significant after adjusting for 
weight indicating the importance of increased mechanical load on the lower limb joints. 
Interestingly, the association of MetS and hand OA remained significant even after adjusting 
for weight.  
Most previous studies have focused their attention on lower limb OA and/or radiographic 
hand OA, however to the best of our knowledge none has studied the association between the 
accumulation of metabolic factors and painful hand ROA.  
The aims of our study were: 1) to assess the association of components of MetS, either singly 
or additively, with painful and painless ROA affecting two different sites (knee or hand) and, 
2) to describe whether this association varies with the site of the affected joint in a 
community-based cohort of middle-aged women. 
 
2. METHODS 
We used cross-sectional data from the Chingford 1000 Women Study, a prospective 
population-based longitudinal cohort of middle-aged women
19
. All women aged 45 or above 
and registered at a general practice in Chingford (North London, UK) were contacted in 
1988-1989 and asked to participate. Out of 1353 women contacted, 1003 (78% response rate) 
attended the baseline visit. The cohort has been shown to be representative of this group of 
women in England in terms of basic characteristics, with the exception of a lower rate of 
current smokers 
19-23
.  
The study was approved by the local ethics committee and written consent was obtained from 
all participants. 
2.1.Exclusion criteria 
We excluded women with rheumatoid arthritis (RA) and those who did not have data 
available on either knee or hand pain and/or radiographic at baseline (ntotal=51). 
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2.2.Assessment of joint-specific radiographic OA and pain (outcome) 
A physical examination was performed at baseline, with anteroposterior (AP) radiographs of 
the hands and weight-bearing anteroposterior view (AP) radiographs of the knee. The 
protocols for radiographic grading and reproducibility for knee and hand ROA have been 
previously reported 
22,24
. Women were classified as having knee ROA if they had a Kellgren–
Lawrence (K/L) OA grade of ≥2 in at least one knee. Hand radiographs were also graded for 
OA: summary scores of distal and proximal interphalangeal (DIP and PIP) joints were 
defined as the number of joints with K/L grade ≥2, while hand ROA in any  interphalangeal 
joint (IPJ) was defined as positive if the K/L score in at least one joint was ≥2. 
Knee and hand pain was assessed as part of a standardised joint symptom questionnaire 
administered by a nurse. It contained information on onset, duration (months), and presence 
(yes/no) for each one of the three following symptoms: pain, stiffness and swelling. Knees 
and hands were considered to be symptomatic if pain and/or stiffness in the knee or DIP and 
PIP joints was reported to be present. 
The sample was divided into four mutually exclusive subgroups based on the presence or 
absence of pain and ROA 
25
: 
 
1. Neither ROA nor pain (Pain−/ROA−; reference category). 
2. ROA only (Pain−/ROA+) 
3. Pain only (Pain+/ROA−) 
4. Painful ROA (Pain+/ROA+: joint(s) with ROA and pain or stiffness affecting the same 
site) 
 
Women with ROA at one site and pain only at the contralateral site were classified as having 
ROA-/Pain+ (n=4 and n=3 women for knee and hand, respectively), because we used the 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
8 
 
‘highest’ category based on this OA classification. 
2.3.Metabolic syndrome (exposure) 
MetS was defined according to the Joint Scientific Statement National Cholesterol Education 
Program III 
26
. Presence of MetS was diagnosed when 3 or more of the following criteria 
were met: elevated waist circumference (≥88 cm), elevated serum triglycerides (≥1.7 
mmol/L), reduced high-density lipoprotein cholesterol (HDL-c) (<1.3 mmol/L), hypertension 
(systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg) and 
elevated fasting blood glucose (≥5.6 mmol/L). Women taking medications for dyslipidaemia, 
hypertension or diabetes were regarded as having dyslipidaemia, hypertension or impaired 
glucose tolerance, respectively. Systolic and diastolic blood pressure readings were 
performed using a calibrated sphygmomanometer, and fasting serum samples were taken for 
estimation of serum lipid profile and blood glucose
23
. 
 
2.4.Covariates  
The following variables collected at baseline were included in the analysis: age and BMI. 
They were treated as continuous variables.  
 
2.5.Statistical analysis 
Data analysis was performed using Stata software version 13.1 (StataCorp, College Station, 
Texas). Characteristics for participants were assessed using mean and standard deviation 
(SD) or median and interquartile range (IQR) for continuous variables and relative and 
absolute values for categorical variables. 
 
To address potential bias and increase precision in this analysis as a result of missing values, 
multiple imputation was used
27
. Missing data of some needed variables to calculate number 
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of MetS were observed in 9 (0.9%) to 365 (38.3%) women (see online supplementary file 
Table S1). The approach of multiple imputation followed by deletion
28
 was followed, 
imputing missing information for all women, but then excluding those with missing data on 
outcomes. Multivariate imputation by chained equations (MICE) was used which assumes 
that data are Missing At Random (MAR).  
The mechanism of missing data was assumed to be MAR because the underlying values 
necessary to calculate MetS that were missing for some women are likely to depend on 
observed data in the Chingford data. The imputation equations included all metabolic 
components, outcome variables, covariates included in this study, as well as additional 
variables available on the dataset including menopause status, pain medication, smoking 
status, alcohol intake, physical activity (times/per week), and occupation (manual/non-
manual). Logistic regression was used for the binary variables (individual component of 
MetS). Two hundred imputed cycles were performed to generate the data set, and the 
resulting estimates were combined using Rubin’s rules. The imputations were assessed by 
hand (supplementary Tables S2, S3 and S4 compare the distribution and associations with 
outcome of imputed variables in the imputed data set and the observed data (with no 
imputation)) and by using graphical methods. Similar results were observed between imputed 
and observed data sets. 
Multinomial logistic regression analysis adjusted for age and then for BMI were conducted to 
calculate relative-risk ratios (RRR) and 95% confidence intervals (CI) and assess the effect of 
MetS status, severity of MetS (assessed as the sum of MetS components and analyzed as a 
continuous variable, range 0–5) and each of its individual components on site-specific OA 
and pain (knee and hand). ‘Neither ROA nor pain’ was used as the reference group. Two 
separate analyses were conducted for knee and hand. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
10 
 
Several sensitivity analyses were conducted. First, a sensitivity analyses was performed to 
assess a more inclusive cohort, comprising only women without joint pain and K/L=0 as the 
reference group. A second sensitivity analysis was performed where each subgroup for 
specific joint (knee or hand) was adjusted for presence or absence of other OA (knee and/or 
hand). Third, women with 2 or more affected IPJ joints with K/L grade 2 or higher were 
classified as having hand ROA. Finally, to examine whether differences in the phenotype of 
the different hand joints exist 
29
, associations between MetS and hand OA based on the first 
carpometacarpal joint (CMC) were assessed in isolation. 
 
3. RESULTS 
3.1.Participants’ characteristics 
Of the 1003 eligible women in the Chingford study, 952 (95.0%) women did not have RA 
and had complete data on knee and hand pain and/or radiographic information (Figure 1).  
Demographic and clinical characteristics of included women are shown in Table 1. The 
median (IQR) age was 54 (49-60) years and the prevalence of MetS among the participants 
was 11.8%. 
The most prevalent MetS component was hypertension (57.2%), followed by low HDL-c 
(19.3%), hypertriglyceridemia (16.6%), high waist circumference (15.7%) and raised fasting 
glucose (8.3%). The prevalence of painful knee and hand ROA was 7.1% and 12.4% 
respectively. 
Distribution of the five components of MetS by joint-specific ROA and pain group are 
described in online supplementary file Tables S5 and S6. Overall, hypertension, abnormal 
waist circumference, triglycerides, HDL-c and fasting glucose (in the context of MetS 
definition) were higher among women with painful knee and/or hand OA. However, higher 
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waist circumference was significantly different only among knee OA groups and higher level 
of triglycerides and fasting glucose among IPJ OA groups. 
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3.2.Association between the presence and the number of MetS components and 
painful knee and hand ROA 
Multinomial logistic regression results on the association between the presence and the 
number of MetS components on knee and hand OA are displayed in Table 2. Results from 
age-adjusted analyses indicated that women with MetS had a significantly greater risk of 
having painful knee ROA than those with neither knee ROA nor knee pain. The RRR (95% 
CI) for ≥three MetS components vs no MetS components was 4.3 (1.4-12.4). After adjusting 
for BMI, associations between MetS and painful knee OA were no longer statistically 
significant (RRR (95% CI): 1.3 (0.4-4.4) and 1.0 (0.7-1.3) for ≥three MetS components vs 
none components and number of MetS components, respectively). 
 
There were significant associations between the presence and the number of MetS with IPJ 
OA groups and the association remained after controlling for BMI. Interestingly, RRRs were 
higher for those with ROA (painful or painless) than the group with knee pain only. 
Increase in the number of MetS components resulted in increased risk of painful hand ROA 
by 50%. 
 
3.3.Association between individual components of MetS and knee and hand OA 
The age and BMI adjusted associations between individual components of MetS and painful 
knee and IPJ ROA are presented in Figure 2 and 3, respectively.  
High waist circumference was the only metabolic component significantly associated with 
higher risk of painful knee ROA (p<0.001). However, after adjusting for BMI, this 
association became nonsignificant (Figure 2). 
Hypertriglyceridemia, low HDL-c levels, hypertension and high fasting glucose were 
correlated with painful IPJ ROA (Figure 3). Among these factors, high fasting glucose had 
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the strongest correlation with painful IPJ ROA (RRR (95% CI): 3.0 (1.3-7.2)). After 
adjusting for BMI, all factors remained statistically significant except HDL-c. Waist 
circumference was the only component that did not show a statistically significant association 
with painful IJP ROA (RRR (95% CI): 0.9 (0.5-1.5)) 
 
3.4.Sensitivity analyses 
No substantial differences in the results were seen after participants with K/L grade =1 were 
excluded from the reference groups, or after adjusting each model for concurrent OA 
affecting other examined joints (see Supplementary Table S7). In addition, similar results 
were found after women were classified as having hand OA if they presented 2 or more 
affected IPJ joints with a K/L grade of ≥2 (see Supplementary Table S7). 
After re-running the analysis for CMC OA, no association between number of MetS and any 
CMC OA groups were found (see Supplementary Table S8).  
 
4. DISCUSSION 
This study suggests that MetS is associated with painful knee OA, independent of age, in this 
community-based cohort of middle-aged women. However, after adjusting for BMI, this 
association was no longer significant, suggesting that the majority of this association may be 
explained by higher weight. On the other hand, a statistical association between the presence 
and number of MetS and painful IPJ ROA was found even after adjusting for age and BMI. 
When evaluating the five components of MetS separately, high waist circumference was the 
only metabolic component strongly associated with knee OA; however, this association 
became non-significant when BMI was adjusted. Hypertriglyceridaemia, hypertension and 
raised fasting glucose levels were significantly associated with painful IPJ ROA.  
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To our knowledge, this is the first community-based study where there has been additional 
sensitivity analysis adjusting for OA at the other joints (see Supplementary Table 7). A strong 
independent association between hand OA and the risk of developing knee OA has been 
reported in a few independent large population based studies 
30-32
. This may be due to 
potential confounding in studies looking at MetS and hand OA without adjusting for presence 
of OA affecting lower limbs.  
Previous studies have shown an association between MetS and knee OA, however the 
definition of MetS and OA has not been consistent. The majority of studies have focused on 
an older population and those at higher risk of OA 
15,33
, therefore our findings may not be 
directly comparable with previous publications. Our findings are consistent with previous 
studies in middle-age populations that have demonstrated an association between MetS and 
knee OA, although this was attenuated and not significant after adjustment for BMI 
34,35
.  
 
High BMI is a risk factor for both MetS and OA affecting the knee and the hand; although the 
association is strongest for knee OA, which would suggest significant role of loading in 
weight bearing joints
5
.  
A previous study has suggested that weight loss is an effective way of reducing the risk of 
symptomatic knee OA
36
. A recently published randomised controlled trial showed that brief 
weight loss interventions offered by GPs in unrelated consultations are cost-effective with 
patients five times more likely to have lost weight a year later
37
. As we have demonstrated 
that the population with MetS is more likely to have knee OA, this group may benefit from 
targeted weight loss interventions to reduce cardiovascular risk.  
 
The mechanisms underlying the association between metabolic factors and hand OA is 
unclear. This association between the accumulation of metabolic factors and painful hand 
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ROA has not previously been reported. Few studies have studied the association between 
metabolic factors and hand ROA 
38-42
, however their findings have been contradictory. Strand 
et. al. 
40,42
 did not find any association between MetS and hand ROA after adjusting for age, 
sex and BMI. Those findings are consistent with the present study for hand ROA without 
concurrent hand pain. However, association between MetS and painful hand ROA was 
statistically significant in our analysis (Figure 3). Dahaghin et. al. 
39
 showed that diabetes, 
hypertension and being overweight were associated with hand OA, which we did not 
demonstrate (RRR (95% CI): 2.2 (0.9-5.6), 0.9 (0.6-1.5) and 0.8 (0.4-1.6) for high fasting 
glucose levels, hypertension and high waist circumference, respectively). These discrepancies 
may be due to differences in the definitions of MetS components, hand OA groups or to the 
lower prevalence of MetS found in this healthy population (11.8%) or differences in the study 
population (particularly - mean age and race). In line with our results, Marshall et. al. 
38
 
identified an association between selected metabolic factors, principally dyslipidaemia, and 
the risk of erosive hand ROA in a population sample of symptomatic individuals.  
 
4.1.Strengths and limitations 
To our knowledge, no other community-based study has described the patterns of metabolic 
dysregulation associated with knee and hand OA in middle-aged women. Our group is 
representative of the general population of this age and gender. Participants were not selected 
based on symptomatology or radiographic features and this allows us to have a control 
population (Pain -/ROA -). We used multiple imputation to minimize selection bias and to 
increase precision
27
.  
Our study has several limitations. First, findings of this study are restricted to middle-age 
women of Caucasian ethnicity. Second, this study is limited by its cross-sectional design and 
our analysis does not indicate causality, but suggests that common pathogenic mechanisms 
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may be involved in women with knee OA, hand OA and MetS. In addition, nowadays a 
substantial proportion of adults who experiencing pain related to knee or hand OA seek 
medical advice, therefore it is important for clinicians to be aware of those associations, 
especially in a view of cardiovascular problems in new users of nonsteroidal medications. 
Third, our dataset had a relatively high proportion of missing values. The use of a multiple 
imputation procedure might be preferable in terms of results validity than complete case 
analysis
27
. Distributions of the variables with missing data between participants with 
observed data and those with imputed data were compared and similar results were found, 
which reinforces our results. Fourth, current knee and hand pain was assessed on a self-
reported joint symptoms questionnaire; therefore we cannot verify that joint pain was 
secondary to OA.. Fifth, some uncontrolled parameters such as physical activity and/or diet 
may have change since this study started in 1988-1989, therefore, the results may not 
generalizable to individuals in 2018. However, our findings are consistent with recent 
studies
15-17,41
 which support that these potential differences may not have any impact on the 
association between number of MetS and site-specific OA. Sixth, number of women taking 
lipids or diabetes medication was smaller. Possible explanations for this may be first, women 
were asking to report their current medication, which may have led to recall and/or 
desirability bias. Second, the diagnostic criteria for diabetes mellitus and high blood 
cholesterol were changed in 1997 and 2002, respectively, 
43,44
 such that conservative 
definitions of serum fasting glucose, triglycerides and HDL ranges were considered. 
Therefore, some women in this study classified as diabetic or/and with dyslipidemia would 
not have been diagnosed with the disease in 1989-90. 
 
4.2. Conclusions 
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In conclusion, data from this study demonstrate that MetS is strongly associated with painful 
IPJ hand OA when compared to the unaffected group. No association was found for knee OA 
when BMI is taking into account. These findings support the concept that OA affecting 
different joints may have different pathogenic pathways. Further attention to MetS and OA at 
different sites is needed to understand the metabolic phenotype in OA. These findings have 
important implications for public health as better control of metabolic factors may further 
improve quality of life for women of middle age. 
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TABLES 
 
Table 1. Baseline characteristics of women in the Chingford study 
Characteristic Participants
a
 (n=952) 
Age (years), median (IQR)  54 (49-60) 
BMI (kg/m
2
), mean (SD) 25.6 ± 4.3 
Waist circumference (cm), mean (SD) 78.0 ± 10.1 
High waist circumference (N=943), n (%)
b
 148 (15.7) 
Triglycerides (mmol/L), mean (SD) 1.18 ± 0.64 
HDL-cholesterol (mmol/L), mean (SD) 1.72 ± 0.45 
Lipids medication, n (%) 4 (0.4) 
High triglycerides (N=607), n (%)
b
 101 (16.6) 
Low HDL-cholesterol (N=587), n (%)
b
 113 (19.3) 
SBP (mmHg), mean (SD) 128.3 ± 20.1 
DBP (mmHg), mean (SD) 78.6 ± 11.4 
BP medication, n (%) 94 (9.9) 
Hypertension (N=933), n (%)
b
 534 (57.2) 
Glucose (mmol/L), mean (SD) 5.00 ± 0.96 
Diabetes medication, n (%) 3 (0.3) 
High fasting glucose (N=604), n (%)
b
 50 (8.3) 
IQR, interquartile range; BMI, body mass index; SD, standard deviation; HDL, high-density lipoprotein; SBP, 
systolic blood pressure; DBP, diastolic blood pressure, RA, rheumatoid arthritis 
a
Number of participants without RA and complete data on both outcome measures. 
b
Percentage was calculated using the information available on each individual variable.  
High waist circumference: ≥88 cm; high triglycerides: ≥1.7 mmol/L or using lipids medication; low HDL 
cholesterol: <1.3 mmol/L or using lipids medication; hypertension: ≥130/85 mmHg or currently using 
antihypertensive medication; high fasting glucose: ≥5.6 mmol/L or currently using anti-diabetic medication 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
23 
 
Table 2. Cross-sectional association of presence and number of metabolic syndrome 
(exposure) with joint-specific pain and ROA (outcome) 
Neither ROA nor pain: 
reference category 
Age-adjusted Age and BMI adjusted 
RRR (95% CI) p-value RRR (95% CI) p-value 
Knee    
Presence of MetS
a
 (≥3 vs. 0)     
ROA only  2.2 (0.8-5.9) 0.139 1.0 (0.3-3.4) 0.996 
Pain only  1.5 (0.8-2.6) 0.164 1.1 (0.6-2.2) 0.700 
Painful ROA 4.3 (1.4-12.4) <0.05 1.3 (0.4-4.4) 0.725 
Number of MetS
a
     
ROA only 1.3 (1.0-1.7) 0.089 1.0 (0.7-1.4) 0.980 
Pain only  1.2 (1.0-1.3) 0.051 1.1 (0.9-1.3) 0.379 
Painful ROA 1.4 (1.1-1.8) <0.005 1.0 (0.7-1.3) 0.990 
Hand (DIP/PIP joints)    
Presence of MetS
a
 (≥3 vs. 0)     
ROA only  2.2 (0.9-5.0) 0.072 2.0 (0.8-5.4) 0.158 
Pain only  0.8 (0.3-1.8) 0.518 0.6 (0.2-1.7) 0.389 
Painful ROA 3.9 (1.7-9.2) <0.005 4.4 (1.7-11.5) <0.005 
Number of MetS
a
     
ROA only 1.3 (1.0-1.6) <0.05 1.3 (1.0-1.7) 0.069 
Pain only  0.9 (0.7-1.2) 0.536 0.9 (0.7-1.2) 0.374 
Painful ROA 1.4 (1.2-1.8) <0.005 1.5 (1.2-2.0) <0.005 
OA, Osteoarthritis; MetS, Metabolic syndrome; ROA, radiographic osteoarthritis; RR, relative-risk ratio; CI, 
confidence intervals; BMI, Body Mass Index 
a
MetS components defined by the National Cholesterol Education Program III are as follows: waist 
circumference: ≥88 cm; triglycerides: ≥1.7 mmol/L or using lipids medication; HDL cholesterol: <1.3 mmol/L 
or using lipids medication; blood pressure: ≥130/85 mmHg or currently using antihypertensive medication; 
fasting glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
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FIGURE LEGENDS 
 
Figure 1. Flow chart of the study 
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Figure 2. Cross-sectional association between individual components of MetS* (exposure) 
and knee painful ROA versus neither ROA nor pain (outcome) 
OA, Osteoarthritis; MetS, the Metabolic syndrome; ROA, radiographic osteoarthritis; RR, risk ratios; CI, 
confidence intervals; HDL-c, high-density lipoprotein cholesterol; BMI, Body Mass Index 
*MetS components defined by the National Cholesterol Education Program III are as follows: waist 
circumference: ≥88 cm; triglycerides: ≥1.7 mmol/L or using lipids medication; HDL cholesterol: <1.3 mmol/L 
or using lipids medication; hypertension: blood pressure≥130/85 mmHg or currently using antihypertensive 
medication; fasting glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
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Figure 3. Cross-sectional association between individual components of MetS* (exposure) 
and hand painful ROA versus neither ROA nor pain (outcome) 
OA, Osteoarthritis; MetS, the Metabolic syndrome; ROA, radiographic osteoarthritis; RR, risk ratios; CI, 
confidence intervals; HDL-c, high-density lipoprotein cholesterol; BMI, Body Mass Index 
*MetS components defined by the National Cholesterol Education Program III are as follows: waist 
circumference: ≥88 cm; triglycerides: ≥1.7 mmol/L or using lipids medication; HDL cholesterol: <1.3 mmol/L 
or using lipids medication; hypertension; blood pressure≥130/85 mmHg or currently using antihypertensive 
medication; fasting glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
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